| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 12/15/2004 | EP1485167A1 1,2-dihydropyrazol-3-ones as cytokine mediators |
| 12/15/2004 | EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases |
| 12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
| 12/15/2004 | EP1485094A1 FORM OF PRESENTATION FOR 3- (2-{ 4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO -METHYL}-1-METHYL-1iH /i -BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO PROPIONIC ACID ETHYL ESTER TO BE ADMINISTERED ORALLY |
| 12/15/2004 | EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 12/15/2004 | EP1484971A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 12/15/2004 | EP1484969A1 Synergistic fungicide compositions containing at least one n-[(2-pyridinyl)methyl]-3-pyridinecarboxamide derivative and one or more further fungicides useful for controlling fungal plant diseases |
| 12/15/2004 | EP1430033A4 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 12/15/2004 | EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 12/15/2004 | EP1373216B1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/15/2004 | EP1337520B1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers |
| 12/15/2004 | EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 12/15/2004 | EP1226125B1 Method for producing therapeutic agents for ulcers |
| 12/15/2004 | EP1226122B1 Bicyclic vasopressin agonists |
| 12/15/2004 | EP1176963B1 Use of dopamine d 3 receptor antagonists for producing medicaments for treating kidney disorders |
| 12/15/2004 | EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
| 12/15/2004 | CN1555367A 3-substituted-4-pyrimidone derivatives |
| 12/15/2004 | CN1555364A Insecticidal diamides |
| 12/15/2004 | CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity |
| 12/15/2004 | CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 12/15/2004 | CN1554656A Yunnan tolal biological coronaridine and its salts and preparing method and use |
| 12/15/2004 | CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications |
| 12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
| 12/15/2004 | CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors |
| 12/15/2004 | CN1179948C HIV protease inhibitors |
| 12/15/2004 | CN1179945C Indole derivatives, process for preparation of same and use thereof |
| 12/15/2004 | CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
| 12/14/2004 | US6831175 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine |
| 12/14/2004 | US6831096 Effective against both A and B forms of influenza; oral bioavailability |
| 12/14/2004 | US6831094 For therapy of central nervous system disorders such as anxiety, depression, motor disorders |
| 12/14/2004 | US6831089 1,4-di-substituted piperidines, some of which have M2 selectivity even higher than that of 3-alpha-chloroimperialine for treating cognitive disorders such as Alzheimer's disease |
| 12/14/2004 | US6831087 2-(Pyrid-2- or 4-yl)-1,2,3,4-tetrahydroisoquinoline and derivatives; a good affinity to the NMDA receptor (N-methyl-D-asparate); acute/cronic neurodegenerative diseases; bacterial/viral infections; antidepressants; analgesics |
| 12/14/2004 | US6831085 Methods and compositions utilizing quinazolinones |
| 12/14/2004 | US6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof |
| 12/14/2004 | US6831082 Method of using soluble epoxide hydrolase inhibitors |
| 12/14/2004 | US6831078 3-aryl substituted having halo or alkylhalo groups; anxiety, epilepsy; presurgery muscle relaxant |
| 12/14/2004 | US6831075 Heterocyclic substituted pyrazolones |
| 12/14/2004 | CA2136075C Heterocyclic ether compounds that enhance cognitive function |
| 12/10/2004 | WO2004108677A1 Antithrombotic ethers |
| 12/09/2004 | WO2004106493A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 12/09/2004 | WO2004106326A1 Novel polymorphs of imatinib mesylate |
| 12/09/2004 | WO2004106325A1 Prodrugs of 1-(1-hydroxy-5-isoquinolinesulfonyl)homopiperazine |
| 12/09/2004 | WO2004106324A1 Azolecarboxamide herbicides |
| 12/09/2004 | WO2004106323A1 Method for producing cyclic diamine derivative or salt thereof |
| 12/09/2004 | WO2004106322A2 Polymorphs of aripiprazole |
| 12/09/2004 | WO2004106310A1 Novel 3-substituted-1,4-benzodiazepines |
| 12/09/2004 | WO2004106308A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors |
| 12/09/2004 | WO2004106307A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 12/09/2004 | WO2004106305A1 New p2x7 receptor antagonists and their use |
| 12/09/2004 | WO2004106302A1 Novel substituted 3-sulfur indoles |
| 12/09/2004 | WO2004106299A2 Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 12/09/2004 | WO2004106296A2 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| 12/09/2004 | WO2004106289A1 Protease inhibitors |
| 12/09/2004 | WO2004105757A2 Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy |
| 12/09/2004 | WO2004105752A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 12/09/2004 | WO2004094388A3 Indazole derivatives as jnk inhibitors |
| 12/09/2004 | WO2004089901A3 Phospholipase c inhibitors for use in treating inflammatory disorders |
| 12/09/2004 | WO2004089892A3 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
| 12/09/2004 | WO2004075863A3 Cxcr3 antagonists |
| 12/09/2004 | WO2004069794A9 New arylpiperazinyl compounds |
| 12/09/2004 | WO2004061084A8 Modulation of protein functionalities |
| 12/09/2004 | WO2003104206A3 Herbicidally active heterocyclylalkynes |
| 12/09/2004 | WO2003102588A3 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 12/09/2004 | WO2003080582A3 Fredericamycin derivatives |
| 12/09/2004 | US20040249185 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate |
| 12/09/2004 | US20040249161 Biphenyl-derivatives as p38-kinase inhibitors |
| 12/09/2004 | US20040249155 1-(omego-substituted-2-[(hetero)arylcarbonylamino]alkanoyl)-4-(1-methylpiperidin-4-yl)piperidine derivatives; e.g., 1-[N-(Indole-6-carbonyl)-D-serinyl]-4-(1-methylpiperidin-4-yl)piperidine Hydrochloride |
| 12/09/2004 | US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors |
| 12/09/2004 | US20040249151 Chemical compounds |
| 12/09/2004 | US20040248961 Oxidation base compound has the nitrogen-based quaternary onium group; oxidation dye precursors; hair coloring with oxidizer; multi-compartment kit; chromatic, fast coloration |
| 12/09/2004 | US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/09/2004 | US20040248941 such as 4-[2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol-1-yl]-1,3-dioxolan-2-one, used as prodrugs to lansoprazole; proton pump inhibitors; antiulcer agents |
| 12/09/2004 | US20040248940 enantiomorphs of pantoprazole magnesium hydrate, used for prevention of gastrointestinal disorders |
| 12/09/2004 | US20040248938 Substituted piperidines |
| 12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
| 12/09/2004 | US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 12/09/2004 | US20040248931 Poly(ADP-ribose)polymerase inhibitors; cerebral infarction; such as 3-[2-(3-hydroxypyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one; synthesis |
| 12/09/2004 | US20040248923 Novel 4-anilinoquinoline-3-carboxamides |
| 12/09/2004 | US20040248922 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 12/09/2004 | US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 12/09/2004 | US20040248918 Anticancer agents |
| 12/09/2004 | US20040248914 Method for the treatment of overactive bladder |
| 12/09/2004 | US20040248907 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors |
| 12/09/2004 | US20040248902 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
| 12/09/2004 | US20040248899 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 12/09/2004 | US20040248895 Novel guanidino compounds |
| 12/09/2004 | US20040248890 Voltage gated sodium and calcium channel inhibitors |
| 12/09/2004 | US20040248888 Metabotropic glutamate (mGluR5) receptor mediated disorders; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain; containing pyridin-4-ylethynyl functionality |
| 12/09/2004 | US20040248884 Protein kinase inhibitors; antitumor agents; such as 5-methyl-1-quinol-4-ylmethyl-3-(4-trifluoromethanesulfonylphenyl)imidazolidine-2,4-dione trifluoroacetate |
| 12/09/2004 | US20040248883 Novel heteroaryl derivatives, their preparation and use |
| 12/09/2004 | US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine |
| 12/09/2004 | US20040248877 Inducing apoptosis in tumor cells |
| 12/09/2004 | US20040248872 Safe for agricultural or gardening use; effective against insects and mammals |
| 12/09/2004 | US20040248853 Antiinflammatory agents; antihistamines; adult respiratory distress syndrome; antidiabetic agents; inflammatory bowel disorders |
| 12/09/2004 | US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents |
| 12/09/2004 | US20040248740 for controlling undesirable plants |
| 12/09/2004 | US20040248225 Luciferin hydrazides |
| 12/09/2004 | US20040247523 Diagnosing and localizing sites of inflammation and perfusion abnormalities (e.g. reperfusion injury, vulnerable plaque, bacterial endocarditis or cardiac transplant rejection) in a single dual isotope imaging procedure, particularly CT imaging, ultrasound, or scintigraphy. |